Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Uhl Barbara |

Presentations at scientific and public conferences

Feichtinger, J; Hoch, F; Prochazka, K; Uhl, B; Neumeister, P; Greinix, H; Deutsch, A Specific Parameters Taken at Time of Diagnosis Are Associated with Early Progression of Follicular Lymphoma
1. Alpe Adria Hematology Meeting 2024; MAR 15-16, 2024; Graz, AUSTRIA. 2024. [Oral Communication]

 

Schulz, E; Grumaz, S; Hatzl, S; Gornicec, M; Valentin, T; Huber-Krassnitzer, B; Kriegl, L; Uhl, B; Deutsch, A; Greinix, H; Krause, R; Neumeister, P Pathogen detection by metagenomic next-generation sequencing during neutropenic fever in patients with haematological malignancies
BRIT J HAEMATOL. 2023; 201: 21-22.-63rd Annual Scientific Meeting of the British-Society-for-Haematology; APR 23-25, 2023; Birmingham, ENGLAND. [Poster]
Web of Science

 

Brunner, A; Mascher, T; Pansy, K.; Gellner, V; Holl, E; Mokry, M; Aigelsreiter, A; Neumeister, P; Greinix, HT; Beham-Schmid, C; Uhl, B; Deutsch, A Distinct expression signatures of chemokine receptors in primary CNS lymphoma.
Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology. memo 15, 37–67 (2022). 2022; -OeGHO- & AHOP-Frühjahrstagung 2022; APR 8-10; Graz, AUSTRIA. [Poster]
FullText

 

Gaksch, L; Huber-Krassnitzer, B; Uhl, B; Bainschab, A; Sifferlinger, I; Sill, H; Schlenke, P; Rosskopf, K; Beham-Schmid, C; Neumeister, B; Greinix, HT Autologous stem cell transplantation as rescue therapy for prolonged cytopenia after treatment with CD19-targeted chimeric antigen receptor modifed T-cells: two case reports
Frühjahrstagung 2022 der OeGHO; APR 8-10,2022; Graz. 2022. [Poster]
FullText

 

Gaksch, L; Huber-Krassnitzer, B; Uhl, B; Bainschab, A; Sifferlinger, IA; Sill, H; Schlenke, P; Rosskopf, K; Beham-Schmid, C; Neumeister, P; Greinix, HT Autologous stem cell boost for prolonged severe cytopenia after treatment with cd19-car-t-cells for refractory diffuse large b-cell lymphoma -two case reports
BONE MARROW TRANSPL. 2022; 57(SUPPL 1): 141-142. [Poster]
Web of Science FullText

 

Gaksch, L; Uhl, B; Pansy, K; Schukoff, T; Greinix, HT; Beham-Schmid, C; Neumeister, P; Prochazka, KT; Deutsch, AJ Distinct chemokine receptor expression profles are associated with the clinicopathological features of follicular lymphoma
Frühjahrstagung 2022 der OeGHO; AP 8-10,2022; Graz. 2022. [Poster]
FullText

 

Monch, A; Prochazka, K; Greinix, H; Neumeister, P; Deutsch, A; Uhl, B Specific clinical, serologic, and histopathologic Parameters are associated with inferior Survival of Patients with primary CNS Lymphoma
ONCOL RES TREAT. 2022; 45(SUPPL 2):61-61. [Poster]
Web of Science

 

Szmyra, MM; Haingartner, S; Jantscher, S; Pansy, K; Uhl, B; Greinix, HT; Neumeister, P; Bernhart, E; Beham-Schmid, C; Dengler, MA; Klosch, B; Deutsch, AJA The Flavonoid Brusatol Induces Apoptosis in Aggressive Lymphoma Cells and Exhibits Synergistic Effect with Venetoclax
BLOOD. 2022; 140: 4945-4946. Doi: 10.1182/blood-2022-166678 [Poster]
Web of Science FullText FullText_MUG

 

Gaksch, L; Uhl, B; Pansy, K; Schukoff, T; Greinix, H; Beham-Schmid, C; Neumeister, P; Prochazka, K; Deutsch, A Verschiedene Expressionsprofile von Chemokinrezeptoren sind mit der Pathogenese des follikulären Lymphoms assoziiert
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische 2021; OCT 1-4, 2021; Berlin. 2021. [Poster]
FullText

 

Lindahl, C; Unterluggauer, J; Pansy, K; Uhl, B; Prochazka, K; Greinix, H; Weniger, M; Kuppers, R; Beham-Schmid, C; Neumeister, P; Haybaeck, J; Deutsch, A Dysregulated eukaryotic initiation factors may impact on the pathogenesis of primary central nervous system lymphomas
ONCOL RES TREAT. 2019; 42: 82-82. [Poster]
Web of Science

 

Pansy, K; Feichtinger, J; Ehall, B; Uhl, B; Greinix, H; Prochazka, K; Beham-Schmid, C; Neumeister, P; Wrodnigg, T; Fechter, K; Deutsch, AJ; Deregulated CXCR4-CXCL12 Signaling Impacts on the Pathogenesis of DLBCL
Lymphoma Biology-Non-Genetic Studies. 2019; -61st ASH Annual Meeting & Exposition; DEZ 7-10, 2019; Orlando, Florida, USA. [Poster]
FullText

 

Spindelbock, W; Huber-Krassnitzer, B; Uhl, B; Gorkiewicz, G; Greinix, H; Hogenauer, C; Neumeister, P Treatment of acute refractory gastrointestinal graft-versus-host-disease by fecal microbiota transplantation
BONE MARROW TRANSPL. 2019; 54: 294-295.-45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT); MAR 24-27, 2019; Frankfurt, GERMANY. [Poster]
Web of Science

 

Uhl, B; Prochazka, K; Wenzl, K; Beham-Schmid, C; Greinix, HT; Deutsch, AJA; Neumeister, P Substantial differences of the chemokine receptor expression Profile of Richter’s transformed DLBCL compared to de novo diffuse large B-cell lymphoma, transformed follicular lymphoma and GCB-cells.
OeGHO- & AHOP-Frühjahrstagung 2019; ARP 11-13, 2019; Linz, AUSTRIA. 2019. [Poster]

 

Uhl, B; Prochazka, K; Wenzl, K; Hatzl, S; Greinix, HT; Beham-Schmid, C; Neumeister, P; Deutsch, A Differences of the chemokine receptor expression profile of aggressive lymphoma and GCB-cells and probable influence on clinical outcome
ONCOL RES TREAT. 2019; 42: 83-83. [Poster]
Web of Science

 

Bärnthaler, Th; Jandl, K; Sill, H; Uhl, B; Schreiber, Y; Thomas, D; Schicho, R; Marsche, G; Frank, S; Heinemann, A; Schuligoi, R IMATINIB AND NILOTINIB ARE STRONG STIMULATORS OF PGE2 SYNTHESIS AND ATTENUATE INFLAMMATORY CYTOKINE RELEASE VIA EP4 RECEPTOR ACTIVATION.
7th European Workshop on Lipid Mediators; SEP 12-14, 2018; Brussels, BELGIUM. 2018. [Poster]

 

Hatzl, S; Kreuzer, P; Lueger, A; Eisner, F; Uhl, B; Jud, P; Tension hydropneumothorax after transbronchial lung biopsy
9. Kongress der Arbeitsgemeinschaft für Notfallmedizin; APR 5-7, 2018; Graz, AUSTRIA. 2018. [Poster]

 

Thomas Bärnthaler, Katharina Jandl, Rudolf Schicho, Barbara Uhl, Florian Reichmann, Magdalena Grill, Gunther Marsche, Heinz Sill, Akos Heinemann, Rufina Schuligoi Imatinib inhibits TNFα via PGE2 and the EP4 receptor
23rd Scientific Symposium of the Austrian Pharmacological Society APHAR; Sept 28-29, 2017; Insbruck, Austria. 2017. [Poster]

 

Thomas Bärnthaler, Katharina Jandl, Rudolf Schicho, Barbara Uhl, Florian Reichmann, Magdalena Grill, Gunther Marsche, Heinz Sill, Akos Heinemann,Rufina Schuligoi Imatinib inhibits TNF-alpha expression via PGE2 and the EP4 receptor
ÖGMBT Annual Meeting 2017, Molecular and cellular mechanisms of human diseases; Sept 25-27, 2017; Innsbruck, Austria. 2017. [Poster]

 

Thomas Bärnthaler, Katharina Jandl, Rudolf Schicho, Barbara Uhl, Florian Reichmann, Magdalena Grill, Gunther Marsche, Heinz Sill, Akos Heinemann,Rufina Schuligoi Imatinib inhibits TNF-alpha expression via PGE2 and the EP4 receptor
Doctoral Day of the Medical University of Graz 2017; Dec 13, 2017; Graz, Austria. 2017. [Poster]

 

Uhl, B; Wenzl, K; Fechter, K; Prochazka, KT; Beham-Schmid, C; Greinix, HT; Neumeister, P; Deutsch, A; CCR7 expression is associated to favourable cancer specific survival of aggressive lymphoma patients.
OeGHO Frühjahrstagung 2017; APR 6-8, 2017; Bregenz, AUSTRIA. 2017. [Poster]

 

Thomas Bärnthaler, Katharina Jandl, Rudolf Schicho, Barbara Uhl, Florian Reichmann, Magdalena Grill, Gunther Marsche, Heinz Sill, Akos Heinemann,Rufina Schuligoi Imatinib inhibits TNF-alpha expression via PGE2 and the EP4 receptor
22nd Scientific Symposium of the Austrian Pharmacological Society Joint meeting with the Hungarian Society for Experimental and Clinical Pharmacology ; Dec 8-10, 2016; Vienna, Austria. 2016. [Poster]

 

Thomas Bärnthaler, Katharina Jandl, Rudolf Schicho, Barbara Uhl, Florian Reichmann, Magdalena Grill,Gunther Marsche, Heinz Sill, Akos Heinemann,Rufina Schuligoi Imatinib inhibits TNF-alpha expression via PGE2 and the EP4 receptor
Doctoral Day of the Medical University of Graz; Dec 14, 2016; Graz Austria. 2016. [Poster]

 

© Med Uni GrazImprint